Hospira introduces first biosimilar mAb Inflectra in some European markets
Inflectra is a chimeric human murine monoclonal antibody that binds with high affinity to both soluble and transmembrane forms of TNF alpha but not to lymphotoxin a (TNF
Inflectra is a chimeric human murine monoclonal antibody that binds with high affinity to both soluble and transmembrane forms of TNF alpha but not to lymphotoxin a (TNF
BXQ-350 is a nanovesicle formulation of Saposin C (sphingolipid activator protein C) and the phospholipid dioleoylphosphatidylserine (DOPS). Earlier, the company secured a Phase II Bridge Award (Small Business
The company has reported that ONS-3010 met the primary endpoints in its first-in-human study, which was conducted by the Centre for Human Drug Research (CHDR) in Leiden, The
ZYAN1 is an orally bioavailable hypoxia-inducible factor-prolyl hydroxylase (HIF-PH) inhibitor being developed to increase the natural production of erythropoietin (EPO) as well as the efficacy of injectable EPO
The launch follows a decision from the US District Court for the District of New Jersey that US Patent No. 7,524,834 is invalid, and AstraZeneca’s request for a
Erbitux is a highly active IgG1 monoclonal antibody that targets the epidermal growth factor receptor (EGFR). Merck has already positioned Japan as its regional Research and Development hub
The approval was based on data from a multicenter, randomized, double-blind, placebo-controlled Phase III SELECT trial. A total of 392 patients were included in the trial, in which
The company has submitted a new drug application (NDA) under the FDA’s fast track program and is based on results from the PARADIGM-HF trial, which is claimed to
Kerasal Complete Care brings together two highly effective treatments to restore healthy nail appearance and treat toe and foot skin fungus (athlete’s foot) in a convenient dual-pack. Moberg
The drug is indicated to manage pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate. ALO-02 is an extended-release